Aktuellt
SENASTE
Redeye saw sales and results that were below our expectations. Sales were more or less flat y/y while costs were higher than expected. PFAS represented 37% of sales in the quarter, while the patented Lifeclean products grew by 92% in the quarter. We expect to make minor negative estimates and fair value range changes.
LÄS MER
